| Literature DB >> 30081506 |
Médéric Loyez1, Jacques Albert2, Christophe Caucheteur3, Ruddy Wattiez4.
Abstract
Optical fiber gratings have widely proven their applicability in biosensing, especially when they are coupled with antibodies for specific antigen recognition. While this is customarily done with fibers coated by a thin metal film to benefit from plasmonic enhancement, in this paper, we propose to study their intrinsic properties, developing a label-free sensor for the detection of biomarkers in real-time without metal coatings for surface plasmon resonances. We focus on the inner properties of our modal sensor by immobilizing receptors directly on the silica surface, and reporting the sensitivity of bare tilted fiber Bragg gratings (TFBGs) used at near infrared wavelengths. We test different strategies to build our sensing surface against cytokeratins and show that the most reliable functionalization method is the electrostatic adsorption of antibodies on the fiber, allowing a limit of detection reaching 14 pM by following the guided cladding modes near the cut-off area. These results present the biodetection performance that TFBGs bring through their modal properties for different functionalizations and data processing strategies.Entities:
Keywords: cancer biomarker; cytokeratin; diagnosis; fiber Bragg grating; immunosensing; optical fiber
Mesh:
Substances:
Year: 2018 PMID: 30081506 PMCID: PMC6163579 DOI: 10.3390/bios8030074
Source DB: PubMed Journal: Biosensors (Basel) ISSN: 2079-6374
Figure 1Illustration of the main steps of the three functionalization processes used for the immobilization of antibodies onto silica optical fibre gratings. The first method considered is a covalent binding of anti-CK17 antibodies (A) while electrostatic adsorption (B) and the use of Protein A intermediate are also represented (C).
Figure 2Graph showing bare tilted fiber Bragg gratings spectra after 4, 8, 12 and 16 h in PBS compared to initial measurement in same solution. The bio-responsive modes, which are tracked for biosensing and located near the cut-off wavelength are stable over time.
Figure 3Near-IR spectra of one bare-TFBG functionalized with anti-CK17 antibodies, immersed into PBS and 10−6 CK17 solution, successively. (a) The first cut-off mode shows the most intense shift after immersion into CK17 solution. (b) After that, each functionalization process was tested for biosensing in growing CK17 concentration from 10−12 to 10−6 g/mL. Graphs show experimental results obtained in triplicates for each condition, using different sensors (mean ± standard deviation) with a linear fitting (red dotted line) for condition B (c).
Figure 4Cut-off area of Bare-TFBG spectrum. (a) The wavelength shifts do clearly indicate an increase in response towards the cut-off mode (near 1529 nm in this case) and also a total lack of response of the device exposed to a large concentration of the wrong target protein (CK7) referred as our negative control (b).